Literature DB >> 22090194

Cardiac PET, CT, and MR: what are the advantages of hybrid imaging?

Antti Saraste1, Juhani Knuuti.   

Abstract

Cardiac hybrid imaging combines different imaging modalities in a way where both modalities equally contribute to image information. Hybrid positron emission tomography-computed tomography (PET-CT) imaging is a promising tool for evaluation of coronary artery disease (CAD) because it enables detection of coronary atherosclerotic lesions by CT angiography and their consequences on myocardial blood flow by PET perfusion in a single study. This appears to offer superior diagnostic accuracy in patients with intermediate risk for CAD compared with stand-alone imaging. Novel, commercially available hybrid scanners containing PET and magnetic resonance as well as development of targeted probes to evaluate molecular and cellular disease mechanisms are expected to provide many new applications for cardiac hybrid imaging. This article focuses on the advantages of cardiac hybrid imaging in the detection of CAD in light of currently available clinical data and discusses the potential future applications.

Entities:  

Mesh:

Year:  2012        PMID: 22090194     DOI: 10.1007/s11886-011-0231-0

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  58 in total

Review 1.  Cardiac computed tomography: indications, applications, limitations, and training requirements: report of a Writing Group deployed by the Working Group Nuclear Cardiology and Cardiac CT of the European Society of Cardiology and the European Council of Nuclear Cardiology.

Authors:  Stephen Schroeder; Stephan Achenbach; Frank Bengel; Christof Burgstahler; Filippo Cademartiri; Pim de Feyter; Richard George; Philipp Kaufmann; Andreas F Kopp; Juhani Knuuti; Dieter Ropers; Joanne Schuijf; Laurens F Tops; Jeroen J Bax
Journal:  Eur Heart J       Date:  2007-12-15       Impact factor: 29.983

Review 2.  Positron emission tomography and molecular imaging.

Authors:  J Knuuti; F M Bengel
Journal:  Heart       Date:  2008-03       Impact factor: 5.994

Review 3.  Identifying and measuring severity of coronary artery stenosis. Quantitative coronary arteriography and positron emission tomography.

Authors:  K L Gould
Journal:  Circulation       Date:  1988-08       Impact factor: 29.690

4.  Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation.

Authors:  Pim A L Tonino; William F Fearon; Bernard De Bruyne; Keith G Oldroyd; Massoud A Leesar; Peter N Ver Lee; Philip A Maccarthy; Marcel Van't Veer; Nico H J Pijls
Journal:  J Am Coll Cardiol       Date:  2010-06-22       Impact factor: 24.094

5.  Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction.

Authors:  R Hachamovitch; D S Berman; L J Shaw; H Kiat; I Cohen; J A Cabico; J Friedman; G A Diamond
Journal:  Circulation       Date:  1998-02-17       Impact factor: 29.690

6.  Reduction of coronary flow reserve in areas with and without ischemia on stress perfusion imaging in patients with coronary artery disease: a study using oxygen 15-labeled water PET.

Authors:  Keiichiro Yoshinaga; Chietsugu Katoh; Kazuyuki Noriyasu; Yasuyoshi Iwado; Hideto Furuyama; Yoshinori Ito; Yuji Kuge; Tetsuro Kohya; Akira Kitabatake; Nagara Tamaki
Journal:  J Nucl Cardiol       Date:  2003 May-Jun       Impact factor: 5.952

7.  Hybrid cardiac imaging: SPECT/CT and PET/CT. A joint position statement by the European Association of Nuclear Medicine (EANM), the European Society of Cardiac Radiology (ESCR) and the European Council of Nuclear Cardiology (ECNC).

Authors:  Albert Flotats; Juhani Knuuti; Matthias Gutberlet; Claudio Marcassa; Frank M Bengel; Philippe A Kaufmann; Michael R Rees; Birger Hesse
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-01       Impact factor: 9.236

8.  Quantification of regional myocardial blood flow in vivo with H215O.

Authors:  S R Bergmann; K A Fox; A L Rand; K D McElvany; M J Welch; J Markham; B E Sobel
Journal:  Circulation       Date:  1984-10       Impact factor: 29.690

9.  Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.

Authors:  Leslee J Shaw; Daniel S Berman; David J Maron; G B John Mancini; Sean W Hayes; Pamela M Hartigan; William S Weintraub; Robert A O'Rourke; Marcin Dada; John A Spertus; Bernard R Chaitman; John Friedman; Piotr Slomka; Gary V Heller; Guido Germano; Gilbert Gosselin; Peter Berger; William J Kostuk; Ronald G Schwartz; Merill Knudtson; Emir Veledar; Eric R Bates; Benjamin McCallister; Koon K Teo; William E Boden
Journal:  Circulation       Date:  2008-02-11       Impact factor: 29.690

Review 10.  Myocardial perfusion scintigraphy: the evidence.

Authors:  S R Underwood; C Anagnostopoulos; M Cerqueira; P J Ell; E J Flint; M Harbinson; A D Kelion; A Al-Mohammad; E M Prvulovich; L J Shaw; A C Tweddel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02       Impact factor: 9.236

View more
  4 in total

1.  Hybrid anatomo-functional imaging of coronary artery disease: Beneficial irrespective of its core components.

Authors:  Francesco Nudi; Giuseppe Biondi-Zoccai; Andrea Romagnoli; Orazio Schillaci; Alessandro Nudi; Francesco Versaci
Journal:  J Nucl Cardiol       Date:  2018-12-18       Impact factor: 5.952

Review 2.  Sequential whole-body PET/MR scanner: concept, clinical use, and optimisation after two years in the clinic. The manufacturer's perspective.

Authors:  Antonis Kalemis; Bénédicte M A Delattre; Susanne Heinzer
Journal:  MAGMA       Date:  2012-08-07       Impact factor: 2.310

3.  [Hybrid imaging in diagnostics and therapy of chronic myocardial ischemia. Clinical value].

Authors:  R Dörr; C T Kadalie; W G Franke; M Gutberlet
Journal:  Herz       Date:  2013-06       Impact factor: 1.443

Review 4.  Multimodality Imaging in Ischemic Cardiomyopathy.

Authors:  John O Prior; Hoshang Farhad; Olivier Muller
Journal:  Curr Cardiovasc Imaging Rep       Date:  2014
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.